Simulation of concentration-time profiles of benzyl-penicillin, enrofloxacin and dihydrostreptomycin in tissue cages in calves

Journal of Veterinary Pharmacology and Therapeutics

Volumn 25, Issue 5, 2002, Pages 389-392

  Bengtsson, B ^a   Greko, Christina ^a  

^a NATIONAL VETERINARY INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROSTREPTOMYCIN; ENROFLOXACIN; PENICILLIN G;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CAGE; CATTLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ELIMINATION; DRUG TISSUE LEVEL; FEMALE; HALF LIFE TIME; MALE; MODEL; NONHUMAN; PRIORITY JOURNAL; SIMULATION; TISSUE WATER;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; CATTLE; DIFFUSION CHAMBERS, CULTURE; DIHYDROSTREPTOMYCIN SULFATE; FEMALE; FLUOROQUINOLONES; INJECTIONS; MALE; PENICILLIN G; QUINOLONES; TISSUE DISTRIBUTION;

ANIMALIA; BOS TAURUS;

EID: 0036441298     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2002.00432.x     Document Type: Article

References (19)

1. Beadle, R.E., Short, C.R., Corstvet, R.E., Pawlusiow, J., Nobles, D.D., McClure, J.R., Guthrie, A.J. & Clarke, C.R. (1989) Characterization of a soft-tissue infection model in the horse and its response to intravenous cephapirin administration. Journal of Veterinary Pharmacology and Therapeutics, 12, 73-86.
2. Bengtsson, B., Bredberg, U. & Luthman, J. (1992) Mathematical description of the concentration of oxytetracycline and penicillin-G in tissue cages as related to the serum concentration. Journal of Veterinary Pharmacology and Therapeutics, 15, 202-216.
3. Bengtsson, B., Luthman, J. & Jacobsson, S.-O. (1984) Evaluation of a tissue-cage model for use in cattle. Acta Veterinaria Scandinavica, 25, 480-493.
4. Brown, S.A. & Riviere, S.A. (1991) Comparative pharmacokinetics of aminoglycoside antibiotics. Journal of Veterinary Pharmacology and Therapeutics, 14, 1-35.
5. Cagni, A., Chuard, C., Vaudaux, P.E., Schrenzel, J. & Lew, D.P. (1995) Comparison of sparfloxacin, temafloxacin and ciprofloxacin for prophylaxis and treatment of experimental foreign body infection by methicillin resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 39, 1655-1660.
6. Chapin-Robertsson, K. & Edberg, S.C. (1991) Measurement of antibiotics in human body fluids: techniques and significance. In Antibiotics in Laboratory Medicine. Ed. Lorian, V. pp. 295-304. Williams-Wilkins, Baltimore/London.
7. Clarke, C.R., Short, C.R., Corstvet, R.E. & Nobles, D. (1989) Effect of Pasteurella haemolytica infection on the distribution of sulfadiazine and trimethoprim into tissue chambers implanted subcutaneously in cattle. American Journal of Veterinary Research, 50, 1551-1565.
8. Hishikawa, T., Kusonoki, T., Tsuchiya, K., Uzuka, Y., Sakamoto, T., Nagatake, T. & Matsumoto, K. (1990) Application of mathematical model to experimental chemotherapy of fatal murine pneumonia. Antimicrobial Agents and Chemotherapy, 34, 326-331.
9. Kaartinen, L., Salonen, M., Alli, L. & Pyörälä, S. (1995) Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. Journal of Veterinary Pharmacology and Therapeutics, 18, 357-362.
10. Kaye, D., Parsons, J.N., Carrizosa, J. & Kobasa, W.D. (1979) Treatment of experimental Staphylococcus aureus abscesses: Comparison of cefazolin, cephalothin, cefoxitin and cefamandole. Antimicrobial Agents and Chemotherapy, 15, 200-203.
11. Knudsen, J.D., Fuurstedt, K., Raber, S., Espersen, F. & Frimodt-Moller, N. (2000) Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy, 44, 1247-1254.
12. MacGowan, A.P., Rogers, C. & Bowker, K. (2000) The use of in vitro pharmacodynamic models of infection to optimize fluoroquinolone dosing regimes. Journal of Antimicrobial Chemotherapy, 46, 163-170.
13. Renard, L., Sanders, J., Laurentie, M. & Delmas, J.-M. (1996) Pharmacokinetic-pharmacodynamic model for spiramycin in staphylococcal mastitis. Journal of Veterinary Pharmacology and Therapeutics, 19, 95-103.
14. Roos, K., Brorson, J.-E. & Holm, S.E. (1985) Studies in vivo on the killing rate and refractory period of penicillin V in an experimental streptococcal infection. Journal of Antimicrobial Chemotherapy, 15, 587-595.
15. US Food and Drug Administration (1977) Code of Federal Regulations. Title 21, Food and drugs parts 300-499. p. 225. US Government printing office, Washington.
16. Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Ebert, S. & Craig, W.A. (1988) Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. Journal of Infectious Diseases, 158, 831-847.
17. Wright, D.H., Brown, G.H., Peterson, M.L. & Rotschafer, J.C. (2000) Application of fluoroquinlone pharmacodynamics. Journal of Antimicrobial Chemotherapy, 46, 669-683.
18. Xuan, D., Zhong, M., Mattoes, H., Bui, K.Q., McNabb, J., Nicolau, D.P., Quintilliani, R. & Nightingale, C.H. (2001) Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model. Antimicrobial Agents and Chemotherapy, 45, 794-799.
19. Zhi, J., Nightingale, C.H. & Quintiliani, R. (1988) Microbial pharmacodynamics of piperacillin in neutropenic mice of systemic infection due to Pseudomonas aeruginosa. Journal of Pharmacokinetics and Biopharmaceutics, 16, 355-375.